secwatch.observer — SEC 8-K summary
======================================

Issuer:     SEELOS THERAPEUTICS, INC. (—)
CIK:        0001017491
Form:       8-K
Filed at:   2024-05-16T23:59:59+00:00
Accession:  0001104659-24-062321
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seelos Therapeutics announces 1-for-8 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-8 ratio, effective May 16, 2024, at 12:01 a.m. ET.
- Authorized shares reduced from 400M to 50M; par value unchanged at $0.001.
- No fractional shares; fractions rounded up to nearest whole share.
- Purpose: meet Nasdaq $1.00 minimum bid price requirement; symbol remains SEEL.
- Outstanding warrants and stock options proportionately adjusted; equity plan shares reduced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1017491/000110465924062321/0001104659-24-062321-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1017491/000110465924062321/tm2414386d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-062321

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer